Literature DB >> 14755300

The importance of being inventive. Critics claim that patents on genes may lead to very broad monopolies and inhibit further innovation. The European patent system provides efficient legal means to address these issues.

Berthold Rutz1, Siobhán Yeats.   

Abstract

Mesh:

Year:  2004        PMID: 14755300      PMCID: PMC1298979          DOI: 10.1038/sj.embor.7400068

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  10 in total

1.  Intellectual property. Patents, secrecy, and DNA.

Authors:  R M Cook-Deegan; S J McCormack
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

2.  Diagnostic testing fails the test.

Authors:  Jon F Merz; Antigone G Kriss; Debra G B Leonard; Mildred K Cho
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

3.  Shares in the human genome--the future of patenting DNA.

Authors:  Sandy M Thomas; Michael M Hopkins; Max Brady
Journal:  Nat Biotechnol       Date:  2002-12       Impact factor: 54.908

4.  Patents and public health. European institutions are challenging Myriad Genetics's patent monopoly on the brca1 gene.

Authors:  Aude Lecrubier
Journal:  EMBO Rep       Date:  2002-12       Impact factor: 8.807

5.  Gene patents and the standard of care.

Authors:  Richard Gold; Timothy A Caulfield; Peter N Ray
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

6.  Impact of gene patenting on R&D and commerce.

Authors:  Mike Stott; Jill Valentine
Journal:  Nat Biotechnol       Date:  2003-07       Impact factor: 54.908

7.  Are DNA patents bad for medicine?

Authors:  David B Resnik
Journal:  Health Policy       Date:  2003-08       Impact factor: 2.980

Review 8.  Genes and patent policy: rethinking intellectual property rights.

Authors:  Lori B Andrews
Journal:  Nat Rev Genet       Date:  2002-10       Impact factor: 53.242

Review 9.  The economics of human gene patents.

Authors:  Frederic M Scherer
Journal:  Acad Med       Date:  2002-12       Impact factor: 6.893

10.  SARS genome patent: symptom or disease?

Authors:  E Richard Gold
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

  10 in total
  2 in total

1.  The economics of biotechnology.

Authors:  Mathias Küelpmann
Journal:  J Biosci       Date:  2005-03       Impact factor: 1.826

2.  Trends in genetic patent applications: the commercialization of academic intellectual property.

Authors:  Jannigje G Kers; Elco Van Burg; Tom Stoop; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2014-01-22       Impact factor: 4.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.